Claritev Corporation Reports First Quarter 2026 Results
Q1 2026 Revenues of $244.7 million grew 5.8%compared to Q1 2025
Net Loss of $73.6 million
Adjusted EBITDA of $146.9 million increased 3.4%compared to Q1 2025
(Adjusted EBITDA Margin of 60.0%versus 61.4%in Q1 2025)
MCLEAN, VA — May 7, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2026.